101 related articles for article (PubMed ID: 19188932)
1. Induction of CD4+CD25+Foxp3+ regulatory T cell response by glatiramer acetate in type 1 diabetes.
Cui G; Zhang Y; Gong Z; Zhang JZ; Zang YQ
Cell Res; 2009 May; 19(5):574-83. PubMed ID: 19188932
[TBL] [Abstract][Full Text] [Related]
2. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
3. CD4(+)CD25(+) regulatory T cells contribute to the therapeutic effects of glatiramer acetate in experimental autoimmune encephalomyelitis.
Jee Y; Piao WH; Liu R; Bai XF; Rhodes S; Rodebaugh R; Campagnolo DI; Shi FD; Vollmer TL
Clin Immunol; 2007 Oct; 125(1):34-42. PubMed ID: 17632037
[TBL] [Abstract][Full Text] [Related]
4. Pro-apoptotic DNA vaccination ameliorates new onset of autoimmune diabetes in NOD mice and induces foxp3+ regulatory T cells in vitro.
Li A; Ojogho O; Franco E; Baron P; Iwaki Y; Escher A
Vaccine; 2006 Jun; 24(23):5036-46. PubMed ID: 16621191
[TBL] [Abstract][Full Text] [Related]
5. IL-15 promotes regulatory T cell function and protects against diabetes development in NK-depleted NOD mice.
Xia J; Liu W; Hu B; Tian Z; Yang Y
Clin Immunol; 2010 Feb; 134(2):130-9. PubMed ID: 19875339
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effect of glatiramer acetate (Copaxone) on immune modulation of experimental hepatic fibrosis.
Horani A; Muhanna N; Pappo O; Melhem A; Alvarez CE; Doron S; Wehbi W; Dimitrios K; Friedman SL; Safadi R
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G628-38. PubMed ID: 17038628
[TBL] [Abstract][Full Text] [Related]
7. Essential roles of TGF-beta in anti-CD3 antibody therapy: reversal of diabetes in nonobese diabetic mice independent of Foxp3+CD4+ regulatory T cells.
Chen G; Han G; Wang J; Wang R; Xu R; Shen B; Qian J; Li Y
J Leukoc Biol; 2008 Feb; 83(2):280-7. PubMed ID: 18029395
[TBL] [Abstract][Full Text] [Related]
8. Ras inhibition increases the frequency and function of regulatory T cells and attenuates type-1 diabetes in non-obese diabetic mice.
Mor A; Kloog Y; Keren G; George J
Eur J Pharmacol; 2009 Aug; 616(1-3):301-5. PubMed ID: 19527709
[TBL] [Abstract][Full Text] [Related]
9. Exendin-4 therapy in NOD mice with new-onset diabetes increases regulatory T cell frequency.
Xue S; Wasserfall CH; Parker M; Brusko TM; McGrail S; McGrail K; Moore M; Campbell-Thompson M; Schatz DA; Atkinson MA; Haller MJ
Ann N Y Acad Sci; 2008 Dec; 1150():152-6. PubMed ID: 19120286
[TBL] [Abstract][Full Text] [Related]
10. Diabetes is not prevented by Foxp3-transduced CD4(+)T cells under the IL-12Rbeta2 promoter control.
Wang R; Han G; Wang J; Song L; Chen G; Xu R; Wang L; Li X; Shen B; Li Y
Mol Immunol; 2008 Aug; 45(14):3814-7. PubMed ID: 18599122
[TBL] [Abstract][Full Text] [Related]
11. Combined insulin B:9-23 self-peptide and polyinosinic-polycytidylic acid accelerate insulitis but inhibit development of diabetes by increasing the proportion of CD4+Foxp3+ regulatory T cells in the islets in non-obese diabetic mice.
Fukushima K; Abiru N; Nagayama Y; Kobayashi M; Satoh T; Nakahara M; Kawasaki E; Yamasaki H; Ueha S; Matsushima K; Liu E; Eguchi K
Biochem Biophys Res Commun; 2008 Mar; 367(4):719-24. PubMed ID: 18194666
[TBL] [Abstract][Full Text] [Related]
12. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
[TBL] [Abstract][Full Text] [Related]
13. Frequency of Foxp3+CD4CD25+ T cells is associated with the phenotypes of allergic asthma.
Matsumoto K; Inoue H; Fukuyama S; Kan-O K; Eguchi-Tsuda M; Matsumoto T; Moriwaki A; Nakano T; Nakanishi Y
Respirology; 2009 Mar; 14(2):187-94. PubMed ID: 19192224
[TBL] [Abstract][Full Text] [Related]
14. Glatiramer acetate improves regulatory T-cell function by expansion of naive CD4(+)CD25(+)FOXP3(+)CD31(+) T-cells in patients with multiple sclerosis.
Haas J; Korporal M; Balint B; Fritzsching B; Schwarz A; Wildemann B
J Neuroimmunol; 2009 Nov; 216(1-2):113-7. PubMed ID: 19646767
[TBL] [Abstract][Full Text] [Related]
15. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo expanded human CD4+CD25+Foxp3+ regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD).
Cao T; Soto A; Zhou W; Wang W; Eck S; Walker M; Harriman G; Li L
Cell Immunol; 2009; 258(1):65-71. PubMed ID: 19410243
[TBL] [Abstract][Full Text] [Related]
18. Prevention of experimental diabetes by Uncaria tomentosa extract: Th2 polarization, regulatory T cell preservation or both?
Domingues A; Sartori A; Golim MA; Valente LM; da Rosa LC; Ishikawa LL; Siani AC; Viero RM
J Ethnopharmacol; 2011 Sep; 137(1):635-42. PubMed ID: 21718770
[TBL] [Abstract][Full Text] [Related]
19. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH
J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
